• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,621
301
265
201
171

COUNTRY

85
42
39
39
38

CATEGORIES

  • 1,185
  • 898
  • 755
  • 291
  • 281
  • 210
  • 206
  • 185
  • 156
  • 124
  • 123
  • 103
  • 89
  • 51
  • 49
  • 49
  • 43
  • 41
  • 36
  • 26
  • 20
  • 20
  • 16
  • 13
  • 10
  • 9
  • 9
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

402
1,022
1,892
3,958

PUBLISHED

9
136
781
3,958

PRODUCT TYPE

3,605
145
126
48
30
3

Search "Company Analysis - Novartis AG" returned 3,958 results.

PRODUCT TITLE
Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis - Product Thumbnail Image

Novartis AG Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Novartis AG Company Profile” is a comprehensive report on Novartis AG. The report provides complete information on the operations, organization structure and financial information details of the company....

October 2014
FROM

Novartis AG (NOVN) - Product Pipeline Analysis, 2014 Update

Summary Novartis AG (Novartis) is a healthcare solutions company. It undertakes the discovery, development and commercialization of a wide range of novel and generic products across various therapeutic...

May 2014
FROM
Novartis AG: Corporate Analysis Novartis AG: Corporate Analysis - Product Thumbnail Image

Novartis AG: Corporate Analysis

This company profile is a premium company information product offering an unmatched depth and breadth of content. It analyzes the strategic positioning of the company - how the company has evolved and...

July 2010
FROM
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM
Novartis AG - Product Pipeline Review - 2013 Novartis AG - Product Pipeline Review - 2013 - Product Thumbnail Image

Novartis AG - Product Pipeline Review - 2013

Novartis AG – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2013” provides data on the Novartis AG’s research and development...

April 2013
FROM
Novartis AG - Product Pipeline Review - 2012 Novartis AG - Product Pipeline Review - 2012 - Product Thumbnail Image

Novartis AG - Product Pipeline Review - 2012

Novartis AG – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Novartis AG - Product Pipeline Review - 2012” provides data on the Novartis AG’s research and development...

November 2012
FROM

Novartis AG - SWOT, Strategy and Corporate Finance Report

Novartis AG - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

June 2013
FROM

Novartis AG - Strategy and SWOT Report

Novartis AG - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings...

December 2014
FROM

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

April 2015
FROM
Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis - Product Thumbnail Image

Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis

The global pharmaceutical industry is expected to reach $1,241 billion by 2016, growing at a CAGR of 5 7% The fragmented market has observed some changes in the competitive landscape during the last...

December 2012
FROM

US OTC Pharmaceutical Market Guide

The US OTC industry is expected to have a market value of $31 9 billion by the end of 2014 In this reserach report, you'll learn about the U S OTC Pharmaceutical Market's competitive landscape, market...

November 2012
FROM

Novartis AG - Product Pipeline Review - 2014

Novartis AG - Product Pipeline Review - 2014 Summary This, ‘Novartis AG - Product Pipeline Review - 2014’, provides an overview of the Novartis AG’s pharmaceutical research and development focus. This...

September 2014
FROM
U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018 U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018 - Product Thumbnail Image

U.S. Vaccine Market - U.S. Industry Analysis, Size, Share, Growth, And Forecast, 2012 - 2018

This report helps to identify factors, which will be the driving force behind the U S vaccine market and sub-markets in the next six years The report provides extensive analysis of the US vaccine industry,...

September 2012
FROM
Novartis AG Nov 12 Novartis AG Nov 12 - Product Thumbnail Image

Novartis AG Nov 12

Abstract Positive track record of above-industry-average growth in pharmaceuticals. Well-diversified product portfolio. Manageable patent expiration schedule. History of significant free cash flow...

November 2012
Austria Vitamins and Dietary Supplements Market, 2010-2012 Austria Vitamins and Dietary Supplements Market, 2010-2012 - Product Thumbnail Image

Austria Vitamins and Dietary Supplements Market, 2010-2012

The total market size for dietary supplements and vitamins in Austria is estimated to reach about $200 million for 2008 (exchange rate $1 = EUR 0 71) Austrians are prone to add vitamin supplements to...

September 2010
FROM
Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World) Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World) - Product Thumbnail Image

Glaxosmithkline Plc and Novartis AG in Consumer Health: Prospects for Their New Joint Venture (World)

Among the largest pharmaceutical companies, both GlaxoSmithKline Plc and Novartis AG are global leaders in consumer health. While manufacturing disruptions and unfavourable market conditions in key...

September 2014
FROM
The Top 50 European Manufacturers of Orthopaedic Implants The Top 50 European Manufacturers of Orthopaedic Implants - Product Thumbnail Image

The Top 50 European Manufacturers of Orthopaedic Implants

Did you know? - Approximately 8 out of 10 people experience severe low back pain at least once in their life - 40% of the population over 70 in the industrialised world suffer from osteoarthritis of...

January 2012
FROM

Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

WinterGreen Research announces that it has published a new study Intraocular Lens (IOL) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018 Worldwide markets are poised to achieve continuing...

February 2013
Brazil Pharmaceutical Market Analysis, 2010-2014 Brazil Pharmaceutical Market Analysis, 2010-2014 - Product Thumbnail Image

Brazil Pharmaceutical Market Analysis, 2010-2014

Having displayed quite healthy growth rates in the years 2005-2008 the Brazil pharmaceuticals market is expected to decelerate slightly in 2009 and stabilize at the level of 7.2% annually till 2014. The...

August 2010
FROM
Thought Leader Insight & Analysis Report - Breast Cancer Q1 2010 Thought Leader Insight & Analysis Report - Breast Cancer Q1 2010 - Product Thumbnail Image

Thought Leader Insight & Analysis Report - Breast Cancer Q1 2010

In this report, the 24th in our Oncology series we summarize the perspectives of six world-class experts in the treatment of breast cancer In this report they provide their opinions on standards of...

March 2010
Loading Indicator

Our Clients

Symantec Corporation Sonoco Products Company Tiffany & Co. ITT Corporation Exxon Mobil Corp. Samsonite International S.A. Kellogg's Co.